[Tyr0] Gastric Inhibitory Peptide (23-42), human

NC(CC[C@@H](C(O)=O)NC([C@H]([C@H](O)C)NC([C@H]([C@@H](C)CC)NC([C@H](CC(N)=O)NC([C@H](CC1=CN=CN1)NC([C@H](CCCCN)NC([C@@H](NC([C@H](CC(O)=O)NC([C@H](CC(N)=O)NC([C@H](CCCCN)NC([C@H](CCCCN)NC(CNC([C@H](CCCCN)NC([C@H](CCC(N)=O)NC([C@H](C)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@@H](NC([C@H](CC(N)=O)NC([C@H](C(C)C)NC([C@@H](N)CC2=CC=C(C=C2)O)=O)=O)=O)CC3=CNC4=CC=CC=C34)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC5=CNC6=CC=CC=C56)=O)=O)=O)=O)=O)=O)=O

[1]LaPelusa A, et al. Biochemistry, Bombesin[M]//StatPearls [Internet]. StatPearls Publishing, 2021.|[2]K Miyawaki, et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A. 1999 Dec 21;96 (26) :14843-7.